Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,006 public trials 1,218 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors

NCT05383872

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • University of California San Francisco San Francisco, California, United States
  • UF Health Shands Hospital Gainesville, Florida, United States
View all 17 locations
View Trial Details
Completed

Validity and Reliability Evaluation of the PRO-CTCAE for Adult-type Diffuse Gliomas Patients in Chinese Population

NCT05486923

Conditions
Adverse Effects, Glioma, Neoplasms, +8 more
Locations
  • Beijing Tian Tan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Xuan Wu Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
  • Guangdong Sanjiu Brain Hospital Guangzhou, Guangdong, China
View all 14 locations
View Trial Details
Completed

Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)

NCT02553642

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +19 more
Locations
  • University of Connecticut Health Center Farmington, Connecticut, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma

NCT02908672

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Oncology Associates, PC - HAL Tempe, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • UC Irvine Medical Center Orange, California, United States
View all 110 locations
View Trial Details
Completed

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Melanoma (Morpheus-Melanoma)

NCT05116202

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • City of Hope Duarte, California, United States
  • The Angeles Clinic and Research Institute - W LA Office Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View all 14 locations
View Trial Details

Related conditions